Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse - PubMed (original) (raw)
Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse
J E Morgan et al. J Cell Biol. 1990 Dec.
Abstract
Dystrophin deficiency in skeletal muscle of the x-linked dystrophic (mdx) mouse can be partially remedied by implantation of normal muscle precursor cells (mpc) (Partridge, T. A., J. E. Morgan, G. R. Coulton, E. P. Hoffman, and L. M. Kunkel. 1989. Nature (Lond.). 337:176-179). However, it is difficult to determine whether this biochemical "rescue" results in any improvement in the structure or function of the treated muscle, because the vigorous regeneration of mdx muscle more than compensates for the degeneration (Coulton, G. R., N. A. Curtin, J. E. Morgan, and T. A. Partridge. 1988. Neuropathol. Appl. Neurobiol. 14:299-314). By using x-ray irradiation to prevent mpc proliferation, it is possible to study loss of mdx muscle fibers without the complicating effect of simultaneous fiber regeneration. Thus, improvements in fiber survival resulting from any potential therapy can be detected easily (Wakeford, S., D. J. Watt, and T. A. Patridge. 1990. Muscle & Nerve.) Here, we have implanted normal mpc, obtained from newborn mice, into such preirradiated mdx muscles, finding that it is far more extensively permeated and replaced by implanted mpc than is nonirradiated mdx muscle; this is evident both from analysis of glucose-6-phosphate isomerase isoenzyme markers and from immunoblots and immunostaining of dystrophin in the treated muscles. Incorporation of normal mpc markedly reduces the loss of muscle fibers and the deterioration of muscle structure which otherwise occurs in irradiated mdx muscles. Surprisingly, the regenerated fibers are largely peripherally nucleated, whereas regenerated mouse skeletal muscle fibers are normally centrally nucleated. We attribute this regeneration of apparently normal muscle to the tendency of newborn mouse mpc to recapitulate their neonatal ontogeny, even when grafted into 3-wk-old degenerating muscle.
Similar articles
- Yields of muscle from myogenic cells implanted into young and old mdx hosts.
Morgan JE, Fletcher RM, Partridge TA. Morgan JE, et al. Muscle Nerve. 1996 Feb;19(2):132-9. doi: 10.1002/(SICI)1097-4598(199602)19:2<132::AID-MUS2>3.0.CO;2-F. Muscle Nerve. 1996. PMID: 8559160 - Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.
Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Partridge TA, et al. Nature. 1989 Jan 12;337(6203):176-9. doi: 10.1038/337176a0. Nature. 1989. PMID: 2643055 - Mdx muscle grafts retain the mdx phenotype in normal hosts.
Morgan JE, Coulton GR, Partridge TA. Morgan JE, et al. Muscle Nerve. 1989 May;12(5):401-9. doi: 10.1002/mus.880120511. Muscle Nerve. 1989. PMID: 2725568 - Magnetic resonance imaging of regenerating and dystrophic mouse muscle.
McIntosh LM, Baker RE, Anderson JE. McIntosh LM, et al. Biochem Cell Biol. 1998;76(2-3):532-41. doi: 10.1139/bcb-76-2-3-532. Biochem Cell Biol. 1998. PMID: 9923723 Review. - Mouse chimeras and genetic rescue of mosaic muscle.
Peterson A, Cross D. Peterson A, et al. Adv Exp Med Biol. 1990;280:173-85. doi: 10.1007/978-1-4684-5865-7_20. Adv Exp Med Biol. 1990. PMID: 2248138 Review.
Cited by
- Enhanced Diaphragm Muscle Function upon Satellite Cell Transplantation in Dystrophic Mice.
Azzag K, Gransee HM, Magli A, Yamashita AMS, Tungtur S, Ahlquist A, Zhan WZ, Onyebu C, Greising SM, Mantilla CB, Perlingeiro RCR. Azzag K, et al. Int J Mol Sci. 2024 Feb 21;25(5):2503. doi: 10.3390/ijms25052503. Int J Mol Sci. 2024. PMID: 38473751 Free PMC article. - Therapeutic approaches for Duchenne muscular dystrophy.
Roberts TC, Wood MJA, Davies KE. Roberts TC, et al. Nat Rev Drug Discov. 2023 Nov;22(11):917-934. doi: 10.1038/s41573-023-00775-6. Epub 2023 Aug 31. Nat Rev Drug Discov. 2023. PMID: 37652974 Review. - Transcriptional reprogramming of skeletal muscle stem cells by the niche environment.
Lazure F, Farouni R, Sahinyan K, Blackburn DM, Hernández-Corchado A, Perron G, Lu T, Osakwe A, Ragoussis J, Crist C, Perkins TJ, Jahani-Asl A, Najafabadi HS, Soleimani VD. Lazure F, et al. Nat Commun. 2023 Feb 1;14(1):535. doi: 10.1038/s41467-023-36265-x. Nat Commun. 2023. PMID: 36726011 Free PMC article. - Development of Therapeutic RNA Manipulation for Muscular Dystrophy.
Saifullah, Motohashi N, Tsukahara T, Aoki Y. Saifullah, et al. Front Genome Ed. 2022 May 10;4:863651. doi: 10.3389/fgeed.2022.863651. eCollection 2022. Front Genome Ed. 2022. PMID: 35620642 Free PMC article. Review. - Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy.
Tanner MK, Tang Z, Thornton CA. Tanner MK, et al. Nucleic Acids Res. 2021 Feb 26;49(4):2240-2254. doi: 10.1093/nar/gkab022. Nucleic Acids Res. 2021. PMID: 33503262 Free PMC article.
References
- J Neurol Sci. 1982 Dec;57(2-3):319-31 - PubMed
- Lancet. 1990 Jul 14;336(8707):114-5 - PubMed
- Dev Biol. 1983 Aug;98(2):520-4 - PubMed
- Proc Natl Acad Sci U S A. 1983 Aug;80(15):4856-60 - PubMed
- Proc Natl Acad Sci U S A. 1984 Feb;81(4):1189-92 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources